The Oncology Clinical Trial Information Commons will include information relating to patient selection criteria, trial locations and patient participation requirements. Biopharma companies will also be able to enter and update their clinical trials on the platform.
The OCTIC platform will be available to clinical trial sponsors and investigators, government registry programs, patient advocacy organizations, health institutions and technology developers.
The program’s founding members are BreastCancerTrials.org, Cancer Commons, Citizen, EmergingMed, GenomOncology, IBM Watson Health, Massive Bio, Quantum Leap Healthcare Collaborative, Genospace/Sarah Cannon Research Institute and Syapse.
More articles on health IT:
Gmail services restored after 3-hour outage
Walmart joins blockchain collaborative to track prescription drugs
Cancer Treatment Centers of America notifies 16,800 patients of another phishing attack
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
